dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2014-05-27T11:29:28Z
dc.date.accessioned2022-10-05T18:50:09Z
dc.date.available2014-05-27T11:29:28Z
dc.date.available2022-10-05T18:50:09Z
dc.date.created2014-05-27T11:29:28Z
dc.date.issued2013-05-07
dc.identifierMedicina (Brazil), v. 46, n. 1, p. 47-55, 2013.
dc.identifier0076-6046
dc.identifier2176-7262
dc.identifierhttp://hdl.handle.net/11449/75368
dc.identifier2-s2.0-84876964265
dc.identifier9740488644443034
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3924305
dc.description.abstractStudy Model: Retrospective study. Study Objective: To characterize statin treatment management due to lipid alterations and side effects throughout statin treatment in basic healthcare unit. Methods: Medical reports of women from a basic healthcare unit were analyzed, obtaining: disease presence, regular medication prescription, statin type and dosage, biochemical exams results, musculoskeletal complaints, and statin use cessation, going back the information until the medical consultation of first prescription. Results: Prescribed statins were Simvastatin and Atorvastatin at low doses (10-20 mg). Dose (48,4%) and/or type (25,4%) alterations occurred for lipid profile adequacy. Lipid levels were reduced without creatine kinase elevation. Treatment withdrawn (30,6%) was mainly due to their own decision (74%), which was strongly associated with records of musculoskeletal complaints (Odds Ratio: 6,40[1,53-26,78]). Conclusion: Statin treatment was effective in reducing serum lipid levels and self-reported pain was underestimated, characterizing the major limiting factor for treatment adherence.
dc.languagepor
dc.relationMedicina (Brazil)
dc.relation0,125
dc.relation0,125
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectDyslipidemias
dc.subjectHMG-CoA
dc.subjectMedication therapy management
dc.subjectPublic health
dc.subjectStatins
dc.subjectatorvastatin
dc.subjectcreatine kinase
dc.subjectlipid
dc.subjectsimvastatin
dc.subjectconsultation
dc.subjectcreatine kinase blood level
dc.subjectdisease association
dc.subjectdisorders of lipid and lipoprotein metabolism
dc.subjectdrug withdrawal
dc.subjectfemale
dc.subjecthealth care facility
dc.subjecthuman
dc.subjectlipid analysis
dc.subjectlipid blood level
dc.subjectlow drug dose
dc.subjectmedical information
dc.subjectmusculoskeletal disease
dc.subjectprescription
dc.subjectretrospective study
dc.titleCaracterização do tratamento medicamentoso com estatinas em unidade básica de saúde
dc.typeArtigo


Este ítem pertenece a la siguiente institución